Skip to main content

Table 3 Baseline characteristics of patients from the included studies

From: Comparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trials

Study/Year

Age (yrs)

Male (%)

Ht (%)

Hc (%)

Cs (%)

Qa

T/D

T/D

T/D

T/D

T/D

 

Lee 2007 [34]

60.9/61.2

64.8/63.6

54.8/55.2

30.0/28.4

37.6/37.2

B

Lee 2008 [5]

61.0/60.7

59.0/57.0

59.5/59.5

30.5/28.5

24.0/31.5

B

Yang 2011 [35]

63.5/63.5

62.3/62.3

55.8/55.8

37.7/37.7

28.6/28.6

B

Yang 2009 [36]

63.4/63.8

40.0/60.0

61.9/57.1

28.6/41.2

14.3/20.6

B

Capranzano 2012 [37]

60.4/60.4

60.2/60.2

91.2/91.2

97.0/97.0

37.1/37.1

B

Angiolillo 2008 [38]

64.0/64.0

60.0/60.0

96.0/96.0

92.0/92.0

24.0/24.0

B

Angiolillo 2011 [39]

60.5/60.5

63.0/63.0

95.0/95.0

100.0/100.0

28.0/28.0

B

Ha 2013 [40]

64.9/62.3

67.7/76.1

71.4/76.1

33.3/42.5

23.8/23.8

B

Lee 2011 [33]

60.9/62.1

70.0/71.5

58.4/64.7

42.4/45.0

30.4/30.1

B

Han 2009 [6]

59.6/60.2

73.8/72.9

57.9/56.1

45.5/45.4

B

  1. Abbreviations:NM not mentioned, Ht hypertension, Hc hypercholesterolemia; Cs current smoker, T triple therapy, D dual therapy
  2. aQuality scale: A:true randomization and allocation concealed; B:process of randomization not given and concealment of allocation unclear